The Standards Working Group comprises members from across the Cannabis sector in the UK.
The Group exists to set and define the standards for the industry around seven critical areas for Cannabis-Based Prescription Medicines (CBPMs).
The main focus of the Standards group is to create dossiers, draft guidelines, and identify areas of concern.
Each of the key areas of focus will seek to:
- Clarify existing standards within the legislation or official guidance documents and make these available where possible in plain language to members.
- Identify areas where standards do not exist, conflict, are ambiguous or unworkable (gap analysis).
- Engage in dialogue with responsible agencies to discover the evidence base for contentious legislation or standards.
- Liaise with membership & other relevant stakeholders about such standards and commission research where evidence is missing.
- Publish research and submissions to support legislative or administrative change and public education on standards.
Areas of focus
Includes all parts of the supply chain from R&D through to Finished Manufacture (includes labelling & packaging) for Medicinal Cannabis and the product recall process.
Includes all parts of the supply chain from R&D through to Finished Manufacture (includes labelling & packaging) for Medicinal Cannabis and the product recall process.
Includes standards for analysis of ingredients beyond CBD & THC, contaminants & diluents, standards for handling requirements for Medicinal Cannabis and liaison with Home Office advisory / working groups and relevant bodies regarding scheduling, standardisation of methodology & certification.
We will establish standardised guidance document formatting and establish standardised complaints documentation and procedures.
